Feb 26, 2026 04:05PM
Feb 10, 2026 06:53AM
Feb 4, 2026 08:02AM
Feb 4, 2026 08:00AM
Oct 29, 2025 04:05PM
Sep 15, 2025 08:32AM
Sep 15, 2025 08:30AM Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Jul 31, 2025 04:05PM
Jul 8, 2025 08:03AM
Jul 8, 2025 08:00AM
Jun 25, 2025 08:05AM
Jun 25, 2025 08:00AM
Mar 19, 2025 06:41AM
Mar 17, 2025 08:01AM OPKO Health (OPK) and Entera Bio (ENTX) Enter into Collaboration Agreement
Mar 17, 2025 08:00AM
Mar 11, 2025 07:07AM
Mar 11, 2025 07:00AM
Jan 27, 2025 08:00AM
Jan 8, 2025 09:27AM
Jan 7, 2025 08:00AM
Nov 8, 2024 04:05PM Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
Nov 7, 2024 08:00AM
Sep 25, 2024 08:31AM
Sep 25, 2024 08:30AM
Sep 16, 2024 07:30AM
Aug 9, 2024 04:05PM
Aug 7, 2024 04:06PM
May 7, 2024 04:05PM OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
Mar 28, 2024 08:01AM
Mar 28, 2024 08:00AM
Mar 20, 2024 08:00AM
Nov 2, 2023 10:00AM
Oct 25, 2023 04:25PM
Sep 12, 2023 08:31AM
Sep 12, 2023 08:30AM Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
Aug 3, 2023 04:05PM
Jun 28, 2023 06:45AM
Jun 28, 2023 06:45AM
May 3, 2023 04:05PM
Mar 9, 2023 08:13AM
Mar 8, 2023 08:03AM
Mar 8, 2023 08:00AM OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Feb 23, 2023 04:05PM
Feb 9, 2023 07:05AM
Nov 8, 2022 04:05PM
Mar 1, 2022 06:00AM
Feb 24, 2022 04:05PM
Feb 15, 2022 11:09AM
Feb 15, 2022 11:08AM Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
Feb 3, 2022 08:32AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All